US-AUSTRALIA DEAL
February 1st, 2004
BY KEITH NUTHALLTHE PHARMACEUTICAL sector is a key element of a free trade agreement recently struck between the USA and Australia, although some onlookers claim Washington failed to achieve many of its aims regarding the industry. Nonetheless, the US Trade Representative's office lauded the fact that Australia would make product-listing procedures within its pharmaceuticals benefits scheme more transparent, notably through the creation of an independent review process. A medicines working group would be established to fuel future USA-Australian cooperation in ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.